Lv43
450 积分 2021-01-20 加入
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction
1天前
已完结
Dynamic chromatin accessibility licenses STAT5- and STAT6-dependent innate-like function of TH9 cells to promote allergic inflammation
7天前
已完结
Turning Off STAT6 with a Targeted Degrader
7天前
已完结
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
7天前
已完结
Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond
7天前
已完结
Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer
21天前
已完结
HER2 testing: evolution and update for a companion diagnostic assay
21天前
已完结
At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapy
27天前
已完结
HER2-targeted therapies beyond breast cancer — an update
27天前
已完结
Emerging importance of HER3 in tumorigenesis and cancer therapy
29天前
已完结
皖公网安备34019202002308
